Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Genitourinary 1

Conditions

Breast Neoplasms 4Neoplasm Metastasis 2Spondylitis, Ankylosing 1Prostatic Neoplasms 1Pain 1Bone Diseases 1

Interventions

Zoledronic Acid 5Bevacizumab 3exemestane 2Therapeutics 2Standard of Care 2Pamidronate 2Oxaliplatin 2Misoprostol 2Magnetic Resonance Spectroscopy 2Letrozole 2Ibandronic Acid 2Fulvestrant 2Fluorouracil 2Cetuximab 2Capecitabine 2vandetanib 1palbociclib 1liposomal doxorubicin 1huaier 1eribulin 1enzalutamide 1darolutamide 1cabozantinib 1aldesleukin 1abemaciclib 1Vindesine 1Trastuzumab 1Sugars 1Stents 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Neoplasm Metastasis × Pamidronate × Clear all
NCT00128297 2023-03-28

Pamidronate Administration in Breast Cancer Patients With Bone Metastases

Spanish Breast Cancer Research Group

Phase 4 Completed
152 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02721433 2020-12-02

REaCT-BTA

Ottawa Hospital Research Institute

Phase 4 Completed
263 enrolled
BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡